BACKGROUND: Near-infrared (NIR) tumor contrast is achieved through the "second-window ICG" technique, which relies on passive accumulation of high doses of indocyanine green (ICG) in neoplasms via the enhanced permeability and retention effect. OBJECTIVE: To report early results and potential challenges associated with the application of second-window ICG technique in endonasal endoscopic, ventral skull-base surgery, and to determine potential predictors of NIR signal-to-background ratio (SBR) using endoscopic techniques. METHODS: Pituitary adenoma (n = 8), craniopharyngioma (n = 3), and chordoma (n = 4) patients received systemic infusions of ICG (5 mg/kg) approximately 24 h before surgery. Dual-channel endoscopy with visible light and NIR overlay were photodocumented and analyzed post hoc. RESULTS: All tumors (adenoma, craniopharyngioma, chordoma) demonstrated NIR positivity and fluoresced with an average SBR of 3.9 ± 0.8, 4.1 ± 1.7, and 2.1 ± 0.6, respectively. Contrast-enhanced T1 signal intensity proved to be the single best predictor of observed SBR (P = .0003). For pituitary adenomas, the sensitivity, specificity, positive predictive value, and negative predictive value of NIR-guided identification of tumor was 100%, 20%, 71%, and 100%, respectively. CONCLUSION: In this preliminary study of a small set of patients, we demonstrate that second-window ICG can provide NIR optical tumor contrast in 3 types of ventral skull-base tumors. Chordomas demonstrated the weakest NIR signal, suggesting limited utility in those patients. Both nonfunctional and functional pituitary adenomas appear to accumulate ICG, but utility for margin detection for the adenomas is limited by low specificity. Craniopharyngiomas with third ventricular extension appear to be a particularly promising target given the clean brain parenchyma background and strong SBR.
BACKGROUND: Near-infrared (NIR) tumor contrast is achieved through the "second-window ICG" technique, which relies on passive accumulation of high doses of indocyanine green (ICG) in neoplasms via the enhanced permeability and retention effect. OBJECTIVE: To report early results and potential challenges associated with the application of second-window ICG technique in endonasal endoscopic, ventral skull-base surgery, and to determine potential predictors of NIR signal-to-background ratio (SBR) using endoscopic techniques. METHODS:Pituitary adenoma (n = 8), craniopharyngioma (n = 3), and chordoma (n = 4) patients received systemic infusions of ICG (5 mg/kg) approximately 24 h before surgery. Dual-channel endoscopy with visible light and NIR overlay were photodocumented and analyzed post hoc. RESULTS: All tumors (adenoma, craniopharyngioma, chordoma) demonstrated NIR positivity and fluoresced with an average SBR of 3.9 ± 0.8, 4.1 ± 1.7, and 2.1 ± 0.6, respectively. Contrast-enhanced T1 signal intensity proved to be the single best predictor of observed SBR (P = .0003). For pituitary adenomas, the sensitivity, specificity, positive predictive value, and negative predictive value of NIR-guided identification of tumor was 100%, 20%, 71%, and 100%, respectively. CONCLUSION: In this preliminary study of a small set of patients, we demonstrate that second-window ICG can provide NIR optical tumor contrast in 3 types of ventral skull-base tumors. Chordomas demonstrated the weakest NIR signal, suggesting limited utility in those patients. Both nonfunctional and functional pituitary adenomas appear to accumulate ICG, but utility for margin detection for the adenomas is limited by low specificity. Craniopharyngiomas with third ventricular extension appear to be a particularly promising target given the clean brain parenchyma background and strong SBR.
Authors: John Y K Lee; John T Pierce; Jayesh P Thawani; Ryan Zeh; Shuming Nie; Maria Martinez-Lage; Sunil Singhal Journal: J Neurosurg Date: 2017-04-07 Impact factor: 5.115
Authors: Isaac Yang; Michael E Sughrue; Martin J Rutkowski; Rajwant Kaur; Michael E Ivan; Derick Aranda; Igor J Barani; Andrew T Parsa Journal: Neurosurg Focus Date: 2010-04 Impact factor: 4.047
Authors: Young Jin Ryu; Seung Hong Choi; Sang Joon Park; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn Journal: PLoS One Date: 2014-09-30 Impact factor: 3.240
Authors: Yash B Singh; Steve S Cho; Rachel Blue; Clare W Teng; Emma De Ravin; Love Buch; John Y K Lee Journal: Oper Neurosurg (Hagerstown) Date: 2021-02-16 Impact factor: 2.703
Authors: John Y K Lee; Steve S Cho; Walter Stummer; Janos L Tanyi; Alexander L Vahrmeijer; Eben Rosenthal; Barbara Smith; Eric Henderson; David W Roberts; Amy Lee; Constantinos G Hadjipanayis; Jeffrey N Bruce; Jason G Newman; Sunil Singhal Journal: J Biomed Opt Date: 2019-12 Impact factor: 3.170
Authors: Alexander Micko; Fabian Placzek; Roger Fonollà; Michael Winklehner; Ryan Sentosa; Arno Krause; Greisa Vila; Romana Höftberger; Marco Andreana; Wolfgang Drexler; Rainer A Leitgeb; Angelika Unterhuber; Stefan Wolfsberger Journal: Front Endocrinol (Lausanne) Date: 2021-10-18 Impact factor: 5.555